Investment firm Mackie Research has updated its coverage on Madalena Ventures, which trades on the TSX Venture Exchange, under the symbol “MVN”. Following the release of an independent evaluation of its unconventional shale resources in Argentina, analyst Bill Newman reiterated his buy recommendation, maintaining his target price of $2.15, giving a projected return of 760% from the $0.25 price the day the report was issued.